Stryker Corporation (SYK) — Stock Price, Chart & Analysis
Stryker Corporation (SYK) is a Healthcare stock currently trading at $274.19, down 0.34% on the day. It carries a market capitalization of $105.52B and a trailing P/E ratio of 28.42. Over the past 52 weeks, SYK has traded between $267.00 and $392.55. Stryker Corporation pays a dividend yielding 1.3%. View the live SYK chart, technical opinion, analyst ratings, fundamentals and latest news below.
Stryker Corporation (SYK) key data
| Price | $274.19 |
| Change (today) | -0.34% |
| Previous close | $275.12 |
| Market cap | $105.52B |
| P/E ratio (TTM) | 28.42 |
| EPS (TTM) | $9.68 |
| Dividend yield | 1.3% |
| 52-week high | $392.55 |
| 52-week low | $267.00 |
| Beta | 0.77 |
| Avg. volume | 2.68M |
| Sector | Healthcare |
| Industry | Medical Devices |
Frequently asked questions about Stryker Corporation (SYK)
How much does one share of Stryker Corporation cost?
As of the latest update, one share of Stryker Corporation (SYK) trades at $274.19 (-0.34% today).
What is Stryker Corporation's market cap?
Stryker Corporation has a market capitalization of approximately $105.52B.
What is Stryker Corporation's P/E ratio?
Stryker Corporation has a trailing price-to-earnings (P/E) ratio of 28.42.
What is Stryker Corporation's earnings per share (EPS)?
Stryker Corporation's trailing twelve-month EPS is $9.68.
Does Stryker Corporation pay a dividend?
Yes — Stryker Corporation pays a dividend with a yield of 1.3% ($3.52 per share annually).
What is Stryker Corporation's 52-week trading range?
Over the past year, SYK has traded between $267.00 and $392.55.
What is the analyst price target for Stryker Corporation?
The mean analyst price target for Stryker Corporation is $369.00. This is informational only and not investment advice.
Latest Stryker Corporation (SYK) news
- Minimally Invasive Robotic Surgical System Market Global Report 2026: Benchmark Intuitive Surgical, Johnson & Johnson, Medtronic, Stryker and Zimmer Biomet NowNews · Sep 23, 2026
- Stryker (SYK) Foot And Ankle Push Keeps Undervalued Narrative In FocusNews · Sep 22, 2026
- Stryker Facing Promising Setup Next Year, Trading Upside Limited in 2026, RBC SaysNews · Sep 17, 2026
- Stryker Expands Foot & Ankle Innovation With Prophecy and smartHEXNews · Sep 17, 2026
- Stryker showcases Foot & Ankle innovation at AOFAS 2026 with Prophecy® Surgical Planning for Incompass™ and Hoffmann® LRF smartHEX™News · Sep 16, 2026
- Why Pay More For Stryker When BSX Stock Is On Sale?News · Sep 14, 2026
Headlines via Yahoo Finance and publishers — click through to read each story at its source.
Loading the live SYK dashboard…